Spain· ES:49750
SILVEDERMA 10 mg/g CREMA
A medicinal product containing sulfadiazina argéntica, registered in Spain by Laboratorio Aldo Union S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- sulfadiazina argéntica
- Manufacturer
- Laboratorio Aldo Union S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cima_codigo700623100EUR 10.54
- cima_codigo70062450EUR 7.31
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfadiazina argéntica in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSILVADENEPfizer Laboratories Div Pfizer Inc
- NetherlandsZilversulfadiazine CF 10 mg/g, crèmeCentrafarm B.V.
- BelgiumFlammacerium 10 mg/g - 22 mg/gEssential Pharma
- United KingdomFlamazine 1% creamWaymade Healthcare Plc
- CanadaFLAMAZINESMITH & NEPHEW INC
- FranceFLAMMAZINE, crèmeALLIANCE PHARMA (IRLANDE)
- FinlandFlamazineSmith & Nephew GmbH
- GermanyFlammazineAlliance Pharma (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Flammazine
- Belgium · Flammazine
- Bulgaria · Дермазин
- Cyprus · Silvederma, Sylfio
- Germany · Flammazine
- Estonia · Sulfargin
- France · Flammazine
- United Kingdom (Northern Ireland) · Flamazine
- Greece · Sylfio
- Croatia · Dermazin
- Hungary · Dermazin
- Italy · Sofargen
- Lithuania · Sulfargin
- Luxembourg · Flammazine
- Latvia · Sulfargin
- Malta · Silvederma
- Netherlands · Flammazine, Zilversulfadiazine Cf
- Portugal · Flammazine
- Romania · Dermazin, Regen-Ag
- Slovenia · Dermazin
- Slovakia · Dermazin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d5c5246-1db0-41a1-a8f5-ac2826b126a4 GET /v1/drugs/3d5c5246-1db0-41a1-a8f5-ac2826b126a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":63068400000}",
"nregistro": "49750",
"substance": "sulfadiazina argéntica"
}See everything about sulfadiazina argéntica.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.